Fig. 1
From: MiR-449b-5p targets lncRNA PSMG3-AS1 to suppress cancer cell proliferation in lung adenocarcinoma
Upregulation of PSMG3-AS1 in LUAD predicted poor survival. Expression levels of PSMG3-AS1 in both LUAD and non-tumor tissues from 64 patients with LUAD were measured by performing RT-qPCR. PCR reactions were repeated 3 times and mean values were presented and compare (a). ***, p < 0.001. The 64 patients were divided into high and low PSMG3-AS1 level groups (n = 32) with the mean value of PSMG3-AS1 expression level in LUAD tissues as a cutoff value. Survival curves were plotted and compared by log-rank test (b)